FDA Approves Stronger Version of Rogaine
- Share via
Associated Press
Pharmacia & Upjohn Inc. has won Food and Drug Administration approval to market a stronger version of its Rogaine anti-baldness drug. The company said it will spend $80 million to advertise and promote Rogaine Extra Strength for Men, which contains 5% of the active ingredient minoxidil, compared with 2% for the original product.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
